IHC was performed to examine the expression of CDK5RAP3, CD68 (macrophage marker) and CD206 (M2 marker) in the centre of the tumour (CT) and invasive margin (IM) (Fig. S4A, B), and the clinicopathological characteristics are shown in Table S1. This evidence concerns the gene CD68 and neoplasm.